The Pharmaceutical Price Regulation Scheme (PPRS) came into force in January 2014, and involved the UK industry effectively ... second part of Sarah Rickwood's overview of the UK market will ...

UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI ...

We asked Tom Delahoyde, managing director at Chiesi UK & Republic of Ireland, his thoughts on the industry’s role in achieving a sustainable future. Why is the pharmaceutical industry so ...

The U.K. government is proposing to raise the rebate rate under a national drug cost program, drawing complaints from the Association of the British Pharmaceutical Industry (ABPI). As one of the ...

The UK government plans to raise the Statutory Scheme payment rate for newer branded medicines from 15.5% to 32.2% of subject ...

The UK has announced plans to abolish NHS England and integrate its functions into the central government, marking a ...

Novo Nordisk A/S (NYSE:NVO) returned to full membership of the Association of the British Pharmaceutical Industry (ABPI) ...